Korro Bio Inc (KRRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -117,260 | -67,218 | -49,157 | -23,387 | -83,581 |
| Depreciation Amortization | 3,791 | 3,164 | 2,032 | 885 | 1,783 |
| Accounts receivable | 727 | 876 | 607 | -228 | -1,696 |
| Accounts payable and accrued liabilities | -2,311 | -1,674 | 1,194 | 99 | -1,341 |
| Other Working Capital | -4,426 | -2,974 | -721 | -3,869 | 13,591 |
| Other Operating Activity | 40,918 | 6,967 | 2,365 | 2,048 | 11,170 |
| Operating Cash Flow | $-78,561 | $-60,859 | $-43,680 | $-24,452 | $-60,074 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 70,700 | 55,700 | 32,901 | 32,900 | 40,900 |
| PPE Investments | -518 | -434 | -259 | -119 | -17,902 |
| Purchase Of Investment | -26,189 | -26,189 | -11,161 | N/A | -146,345 |
| Investing Cash Flow | $43,993 | $29,077 | $21,481 | $32,781 | $-123,347 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 685 | 305 | 177 | 172 | 69,355 |
| Financing Cash Flow | $685 | $305 | $177 | $172 | $69,355 |
| Exchange Rate Effect | 64 | -11 | -9 | N/A | -4 |
| Beginning Cash Position | 59,049 | 59,049 | 59,049 | 59,049 | 173,119 |
| End Cash Position | 25,230 | 27,561 | 37,018 | 67,550 | 59,049 |
| Net Cash Flow | $-33,819 | $-31,488 | $-22,031 | $8,501 | $-114,070 |
| Free Cash Flow | |||||
| Operating Cash Flow | -78,561 | -60,859 | -43,680 | -24,452 | -60,074 |
| Capital Expenditure | -518 | -434 | -259 | -119 | -17,902 |
| Free Cash Flow | -79,079 | -61,293 | -43,939 | -24,571 | -77,976 |